TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
劉志銘LIOU, JYH-MING
- 協同主持人
- 執行臨床試驗年資 17 年 9 個月
-
jyhmingliou@gmail.com
發表文獻
28筆
11
Graham DY, Liou JM. Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship. Clin Gastroenterol Hepatol. 2022 May;20(5):973-983.e1.
12
Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. J Neuroinflammation. 2019 Jun 27;16(1):129. doi: 10.1186/s12974-019-1528-y. PMID: 31248424; PMCID: PMC6598278.
13
Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease. Neurology. 2022 Feb 22;98(8):e848-e858.
14
Chen CC, Chen YN, Liou JM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. From germ theory to germ therapy. Kaohsiung J Med Sci. 2019 Feb;35(2):73-82. doi: 10.1002/kjm2.12011. PMID: 30848026.
15
Kuo SH, Yeh KH, Lin CW, Liou JM, Wu MS, Chen LT, Cheng AL. Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers (Basel). 2022 Feb 16;14(4):1005. doi: 10.3390/cancers14041005.
16
Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel). 2019 Apr 28;11(5):593. doi: 10.3390/cancers11050593. PMID: 31035365; PMCID: PMC6562927.
17
Liou JM, Lee YC, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy.
Gut Liver. 2022 Jan 15;16(1):8-18. doi: 10.5009/gnl20330.
Gut Liver. 2022 Jan 15;16(1):8-18. doi: 10.5009/gnl20330.
18
O'Connor A, Liou JM, Gisbert JP, O'Morain C. Review: Treatment of Helicobacter pylori Infection 2019. Helicobacter. 2019 Sep;24 Suppl 1:e12640. doi: 10.1111/hel.12640. PMID: 31486235.
19
Chen SJ, Chen CC, Liao HY, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease. J Parkinsons Dis. 2022;12(4):1219-1230. doi: 10.3233/JPD-223179.
20
Yeo YH, Hsu CC, Lee CC, Ho HJ, Lin JT, Wu MS, Liou JM, Wu CY; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication. J Gastroenterol Hepatol. 2019 Jan;34(1):59-67. doi: 10.1111/jgh.14462. Epub 2018 Oct 11. PMID: 30169908.
